Shrivastava Sanjay's Form 4 filing
enVVeno Medical Corp (NVNO) · filed Jul 1, 2022
- Accession no.
- 0001493152-22-018361
- Filed
- Jul 1, 2022
- Trade date
- Jun 30, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $3.85K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shrivastava SanjayCIK 0001754588 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $3.85 | +$3,850 | 3,888 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
On June 30, 2022 the reporting person purchased 1,000 shares of common stock in the public market at $3.85 per share.